Advertisement

Evaluation of using fresh frozen plasma for patients with cirrhosis at a tertiary healthcare center in Turkey: Strict transfusion policies are essential

      Abstract

      Aim

      Management of blood transfusions is a critical issue, especially in cirrhotic patients, because of the absence of national policies in many countries. Fresh frozen plasma (FFP) is a common blood component misused excessively in various clinical situations and cirrhosis patients without any scientific rationale. We evaluated the FFP transfusions in patients with cirrhosis at our tertiary care hospital.

      Material and Method

      The cases with cirrhosis diagnosed between 2014 and 2020 were selected using the hospital database. The appropriateness of FFP transfusion was determined based on the Practice Guidance by the American Association for the Study of Liver Diseases and Italian guidelines.

      Result

      Two hundred and six liver cirrhosis patients were identified who received FFP transfusion. The median age was 63 (22–94). Of the 206 patients, 79 (38.3 %) were female, and 127 (61.7 %) were men. The most common causes of liver cirrhosis were alcohol (27.7 %). 45.6 % of the patients were in Child-Pugh Class C. We found 62.1 % of FFP replacements were inappropriately used. Most inappropriate use of FFP (22.8 %, n = 47) occurred to correct prolonged INR in the absence of bleeding.

      Conclusion

      To avoid inappropriate usage of FFP, regular utilization reviews and formal education programs can be helpful. Our clinic has planned to arrange educational programs for physicians to use blood products appropriately and minimize transfusion-related side effects.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bjerrum Oj
        • Jersild C.
        Class-specific Anti-IgA associated with severe anaphylactic transfusion reactions in a patient with pernicious anaemia.
        Vox Sang. 1971; 21: 411-424https://doi.org/10.1111/J.1423-0410.1971.TB04797.X
        • Snyder A.J.
        • Gottschall J.L.
        • Menitove J.E.
        Why is fresh-frozen plasma transfused?.
        Transfusion. 1986; 26: 107-112https://doi.org/10.1046/J.1537-2995.1986.26186124011.X
        • Blumberg N.
        • Laczin J.
        • McMican A.
        • Heal J.
        • Arvan D.
        A critical survey of fresh-frozen plasma use.
        Transfusion. 1986; 26: 511-513https://doi.org/10.1046/J.1537-2995.1986.26687043615.X
        • Nordhagen R.
        • Conradi M.
        • Drömtorp S.M.
        Pulmonary reaction associated with transfusion of plasma containing Anti-5b.
        Vox Sang. 1986; 51: 102-107https://doi.org/10.1111/J.1423-0410.1986.TB00223.X
        • Popovsky M.A.
        Transfusion and the lung: circulatory overload and acute lung injury.
        Vox Sang. 2004; 87: 62-65https://doi.org/10.1111/J.1741-6892.2004.00453.X
        • French C.J.
        • Bellomo R.
        • Angus P.
        Cryoprecipitate for the correction of coagulopathy associated with liver disease.
        Anaesth Intensive Care. 2003; 31: 357-361https://doi.org/10.1177/0310057X0303100403
        • Drebes A.
        • de Vos M.
        • Gill S.
        • Fosbury E.
        • Mallett S.
        • Burroughs A.
        • et al.
        Prothrombin complex concentrates for coagulopathy in liver disease: single‐center, clinical experience in 105 patients.
        Hepatol Commun. 2019; 3: 513https://doi.org/10.1002/HEP4.1293
      1. Fatourou E., International ET-L, 2016 undefined. Transfusion strategies in patients with cirrhosis: less is more. DiscoveryUclAcUk n.d.

        • Søgaard K.
        • Horváth-Puhó E.
        Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study.
        JournalsLwwCom. 2007; (… HG-O journal of the, 2009 undefined)
        • Ambrosino P.
        • Tarantino L.
        • Di Minno G.
        • Paternoster M.
        • Graziano V.
        • Petitto M.
        • et al.
        The risk of venous thromboembolism in patients with cirrhosis.
        Thromb Haemost. 2017; 26: 139-148https://doi.org/10.1160/TH16-06-0450
        • Tripodi A.
        • Mannucci P.M.
        The coagulopathy of chronic liver disease.
        N Engl J Med. 2011; 365: 147-156https://doi.org/10.1056/NEJMRA1011170
        • Beverina I.
        • Novelli C.
        • Gatti A.
        • Aloni A.
        • Grassi C.
        • Latella S.
        • et al.
        Efficacy of a strict surveillance policy towards inappropriateness of plasma transfusion.
        Transfus Apher Sci. 2019; 58: 423-428https://doi.org/10.1016/J.TRANSCI.2019.03.022
      2. Mirzamani N., Molana A., Science EP-T and A, 2009 undefined. Evaluation of appropriate usage of fresh frozen plasma: Results of a regional audit in Iran. Elsevier n.d.

      3. Moiz B., Arif F., MEDICAL KH-J-P, 2006 undefined. Appropriate and inappropriate use of fresh frozen plasma. Citeseer n.d.

        • Duguid J.
        • O’Shaughnessy D.F.
        • Atterbury C.
        • Maggs P.B.
        • Murphy M.
        • Thomas D.
        • et al.
        Guidelines for the use of fresh‐frozen plasma, cryoprecipitate and cryosupernatant.
        Wiley Online Libr. 2004; 126: 11-28https://doi.org/10.1111/j.1365-2141.2004.04972.x
        • Kakkar N.
        • Kaurt R.
        • Dhanoa J.
        Improvement in fresh frozen plasma transfusion practice: results of an outcome audit.
        Transfus Med. 2004; 14: 231-235https://doi.org/10.1111/J.0958-7578.2004.00505.X
      4. Morrison J., Sumrall D., … SC-A journal of, 1993 undefined. The effect of provider education on blood utilization practices. Elsevier n.d.

        • Shanberge J.N.
        Reduction of fresh‐frozen plasma use through a daily survey and education program.
        Transfusion. 1987; 27: 226-227https://doi.org/10.1046/J.1537-2995.1987.27387235625.X
        • Chng W.
        • Tan M.
        An audit of fresh frozen plasma usage in an acute general hospital in Singapore.
        Citeseer. 2016; (journal PK-S medical, 2003 undefined): 574-578
        • Northup P.
        • Garcia-Pagan J.
        (Hepatology GG-T-, 2021 undefined)Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American association for. ApefComPt 2020. 73. 2021https://doi.org/10.1002/hep.31646
        • Giannini E.
        • Giambruno E.
        Low fibrinogen levels are associated with bleeding after varices ligation in thrombocytopenic cirrhotic patients.
        MedigraphicCom. 2018; (… MB-A of, 2018 undefined): 830-835https://doi.org/10.5604/01.3001.0012.0775
        • Dzik W.
        • Rao A.
        Why do physicians request fresh frozen plasma? [1].
        Transfusion. 2004; 44: 1393-1394https://doi.org/10.1111/J.0041-1132.2004.00422.X
        • Tuckfield A.
        • Haeusler M.N.
        • Grigg A.P.
        • Metz J.
        Reduction of inappropriate use of blood products by prospective monitoring of transfusion request forms.
        Med J Aust. 1997; 167: 473-476https://doi.org/10.5694/J.1326-5377.1997.TB126674.X
        • De Pietri L.
        • Bianchini M.
        • Montalti R.
        • De Maria N.
        • Di Maira T.
        • Begliomini B.
        • et al.
        Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial.
        Hepatology. 2016; 63: 566-573https://doi.org/10.1002/HEP.28148
      5. Peng Y., Qi X., Medicine XG-, 2016 undefined. Child–Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. NcbiNlmNihGov n.d.

        • Francoz C.
        • Belghiti J.
        • Vilgrain V.
        Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation.
        GutBmjCom. 2005; 54 (Gut DS-, 2005 undefined): 691-697https://doi.org/10.1136/gut.2004.042796
      6. Hashash J., Thudi K., Gastroenterology SM-, 2012 undefined. An 18-year-old woman with a 15-cm liver mass and an ammonia level of 342. GastrojournalOrg n.d.

      7. Journal HC-BBM, 1993 undefined. Avoiding the misuse of fresh frozen plasma. NcbiNlmNihGov n.d.